ArticleJournal of molecular modeling2025
An investigation of fucoidan as a potential inhibitor against DENV/NS3 proteases through molecular dynamics simulations and DFT studies.
Article in Journal of molecular modeling, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Identification of Potential Inhibitors Targeting Non-Structural Proteins NS3 and NS5 of Dengue Virus Using Docking and Deep Learning Approaches.Pharmaceuticals (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionDengue virus (DENV) is a mosquito-borne disease that spreads in the tropics and subtropics mainly by the Aedes aegypti mosquito, infecting more than 100 million people every year and causing copious deaths every year. As of now, no direct-acting antiviral drugs or vaccines are available to combat DENV. Therefore, the identification of novel small molecules from natural origin becomes inevitable for the management of DENV fever. Here, fucoidan from Padina gymnospora was analyzed for competitive binding within the active site of nonstructural protein NS3 proteases selected as a potential therapeutic target for direct-acting antivirals. METHODOLOGY: The 3D structure of fucoidan was retrieved from Pubchem and molecular targets was fetched from the Protein Data Bank. Molecular docking was performed with Glide module of Schrodinger and molecular dynamics was studied using GROMACS software. Further, density functional theory (DFT) analysis, ADME properties, and BOILED-egg plot analysis were also studied. RESULTS AND DISCUSSION: The fucoidan compound was docked with the active site of NS3 proteases, showing docking score variation between -6.458 and -7.483 kcal/mol and strong interaction with the catalytic dyad His51, Asp75, and Ser135 amino acids. Furthermore, binding free energy was calculated by using prime MM/GBSA to assess the binding affinity of fucoidan towards the target protein. Moreover, molecular dynamics simulation was performed to evaluate the structural stability of the docked complexes. In addition, the small HOMO-LUMO gap of -0.189 eV given by DFT analysis indicated the structural stability between the ligand and the protein. The fucoidan phytocompound has satisfied all the relevant pharmacokinetic properties and is also highly absorbed by the gastrointestinal tract.
conclusionFrom the overall findings of this study, it is concluded that the fucoidan from Padina gymnospora has effectively blocked the catalytic dyad of NS3 proteases, which could be considered a potent inhibitor to control the DENV multiplication infection.
Indexed as
Identifiers
41196423What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.